Sysmex opens its subsidiary in Saudi Arabia

Sysmex, a company specialising in healthcare technology and a world leader in haematology diagnostics and services, celebrated the evening of the opening ceremony of its subsidiary in the Kingdom of Saudi Arabia on 29 November 2022.

The event was attended by multiple Key Opinion Leaders – Fumio Iwai, Japanese Ambassador to Saudi Arabia, Iwane Matsui and Hiroshi Kanda, members of the Managing Board and Senior Executive Officer, Managing Director at Sysmex Corporation, and other members of the management team and senior executives of Sysmex Corporation and Sysmex Europe, Middle East & Africa.

The first part of the event consisted of a visit to the new Sysmex Saudi Arabia (Sysmex LLC) facilities, located in Riyadh city, specifically at the Business Gate. At the end of the visit, the ribbon-cutting ceremony was performed by Iwane Matsui and Hiroshi Kanda.

Subsequently, the Fairmont Hotel ceremony of the new office was attended by the company’s main spokespersons. Wissam Daoud, Managing Director at Sysmex LLC says: “Over the years, Sysmex Middle East FZ-LLC has grown to become one of the Middle East region’s leading diagnostic suppliers with a reputation for high-quality products, service and reliability. Our unique proposition lies in its ability to have direct existence in the Kingdom of Saudi Arabia with a highly competent team and optimal after-sales support. This is what further gives the company a unique edge in the market to be closer to our customers and act with agility to meet our customers’ expectations.”

International reputation

Sysmex ranks among the top diagnostic companies, being a world leader in haematology diagnostics and services. Globally, the company operates in more than 190 countries and regions around the world and employs more than 10,000 people.

Sysmex has a total of eight business lines: haematology, life sciences, urinalysis, primary care, haemostasis and immunochemistry, essential healthcare and flow cytometry.

The company’s net sales at the fiscal year ended March 2022 were 2.79 € billion (¥363.7 billion: €1=¥130), with the EMEA region accounting for 27.9% of that amount.

The Sysmex LLC subsidiary was founded in February 2022. Until then, the Sysmex brand and products had been present in the Saudi market through our distributor Arabian Medical Pharmaceutical Company.